Regeneron Pharmaceuticals Revenue 2010-2023 | REGN

Regeneron Pharmaceuticals annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Regeneron Pharmaceuticals revenue for the quarter ending December 31, 2023 was $3.434B, a 0.58% increase year-over-year.
  • Regeneron Pharmaceuticals revenue for the twelve months ending December 31, 2023 was $13.117B, a 7.76% increase year-over-year.
  • Regeneron Pharmaceuticals annual revenue for 2023 was $13.117B, a 7.76% increase from 2022.
  • Regeneron Pharmaceuticals annual revenue for 2022 was $12.173B, a 24.26% decline from 2021.
  • Regeneron Pharmaceuticals annual revenue for 2021 was $16.072B, a 89.14% increase from 2020.
Regeneron Pharmaceuticals Annual Revenue
(Millions of US $)
2023 $13,117
2022 $12,173
2021 $16,072
2020 $8,497
2019 $6,558
2018 $5,146
2017 $5,872
2016 $4,860
2015 $4,104
2014 $2,820
2013 $2,105
2012 $1,378
2011 $446
2010 $459
2009 $379
Regeneron Pharmaceuticals Quarterly Revenue
(Millions of US $)
2023-12-31 $3,434
2023-09-30 $3,363
2023-06-30 $3,158
2023-03-31 $3,162
2022-12-31 $3,414
2022-09-30 $2,936
2022-06-30 $2,857
2022-03-31 $2,965
2021-12-31 $4,952
2021-09-30 $3,453
2021-06-30 $5,139
2021-03-31 $2,529
2020-12-31 $2,423
2020-09-30 $2,294
2020-06-30 $1,952
2020-03-31 $1,828
2019-12-31 $1,864
2019-09-30 $1,744
2019-06-30 $1,578
2019-03-31 $1,373
2018-12-31 $363
2018-09-30 $1,664
2018-06-30 $1,608
2018-03-31 $1,512
2017-12-31 $1,582
2017-09-30 $1,501
2017-06-30 $1,470
2017-03-31 $1,319
2016-12-31 $1,227
2016-09-30 $1,220
2016-06-30 $1,213
2016-03-31 $1,201
2015-12-31 $1,098
2015-09-30 $1,137
2015-06-30 $999
2015-03-31 $870
2014-12-31 $802
2014-09-30 $726
2014-06-30 $666
2014-03-31 $626
2013-12-31 $610
2013-09-30 $597
2013-06-30 $458
2013-03-31 $440
2012-12-31 $415
2012-09-30 $428
2012-06-30 $304
2012-03-31 $232
2011-12-31 $123
2011-09-30 $103
2011-06-30 $108
2011-03-31 $112
2010-12-31 $134
2010-09-30 $106
2010-06-30 $116
2010-03-31 $104
2009-12-31 $97
2009-09-30 $117
2009-06-30 $90
2009-03-31 $75
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $105.862B $13.117B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.093B 14.42
Bristol Myers Squibb (BMY) United States $105.842B 6.98
Vertex Pharmaceuticals (VRTX) United States $105.310B 30.33
Gilead Sciences (GILD) United States $91.801B 10.97
CSL (CSLLY) Australia $88.459B 0.00
GSK (GSK) United Kingdom $86.842B 10.96
Moderna (MRNA) United States $39.678B 0.00
Biogen (BIIB) United States $31.879B 14.89
Argenex SE (ARGX) Netherlands $22.018B 0.00
BioNTech SE (BNTX) Germany $21.984B 8.02
Illumina (ILMN) United States $20.296B 146.82
Genmab (GMAB) Denmark $19.783B 25.37
Alnylam Pharmaceuticals (ALNY) United States $18.800B 0.00
BeiGene (BGNE) Cayman Islands $16.235B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.824B 67.10
Incyte (INCY) United States $13.106B 21.78
Karuna Therapeutics (KRTX) United States $12.599B 0.00
Sarepta Therapeutics (SRPT) United States $11.554B 0.00
Bio-Techne Corp (TECH) United States $11.400B 42.41
Repligen (RGEN) United States $10.593B 109.79
Legend Biotech (LEGN) United States $10.568B 0.00
Exact Sciences (EXAS) United States $10.476B 0.00
QIAGEN (QGEN) Netherlands $10.050B 20.80
Bio-Rad Laboratories (BIO.B) United States $9.474B 28.22
Ascendis Pharma (ASND) Denmark $8.581B 0.00
Roivant Sciences (ROIV) United Kingdom $8.171B 0.00
Vaxcyte (PCVX) United States $7.556B 0.00
Exelixis (EXEL) United States $6.967B 35.91
Apellis Pharmaceuticals (APLS) United States $6.842B 0.00
Cytokinetics (CYTK) United States $6.715B 0.00
Viking Therapeutics (VKTX) United States $6.287B 0.00
Intra-Cellular Therapies (ITCI) United States $6.271B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.856B 0.00
Blueprint Medicines (BPMC) United States $5.539B 0.00
Zealand Pharma (ZLDPF) Denmark $5.253B 0.00
Halozyme Therapeutics (HALO) United States $5.191B 16.02
Nuvalent (NUVL) United States $5.177B 0.00
Krystal Biotech (KRYS) United States $4.894B 0.00
Alkermes (ALKS) Ireland $4.803B 25.67
Biohaven (BHVN) United States $4.656B 0.00
Immunovant (IMVT) United States $4.436B 0.00
Apogee Therapeutics (APGE) United States $3.992B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.899B 0.00
Iovance Biotherapeutics (IOVA) United States $3.885B 0.00
Insmed (INSM) United States $3.819B 0.00
Arcellx (ACLX) United States $3.729B 0.00
SpringWorks Therapeutics (SWTX) United States $3.710B 0.00
Axsome Therapeutics (AXSM) United States $3.579B 0.00
Fortrea Holdings (FTRE) United States $3.513B 0.00
ImmunityBio (IBRX) United States $3.425B 0.00
Amicus Therapeutics (FOLD) United States $3.391B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.316B 0.00
IDEAYA Biosciences (IDYA) United States $3.303B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.069B 0.00
Arvinas (ARVN) United States $3.054B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.045B 0.00
Immunocore Holdings (IMCR) United Kingdom $3.031B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.019B 0.00
Certara (CERT) United States $2.951B 63.65
Beam Therapeutics (BEAM) United States $2.892B 0.00
Denali Therapeutics (DNLI) United States $2.801B 0.00
Intellia Therapeutics (NTLA) United States $2.720B 0.00
MorphoSys AG (MOR) Germany $2.687B 0.00
Merus (MRUS) Netherlands $2.541B 0.00
Kymera Therapeutics (KYMR) United States $2.480B 0.00
CG Oncology (CGON) United States $2.445B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.426B 0.00
Keros Therapeutics (KROS) United States $2.423B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.406B 0.00
Neumora Therapeutics (NMRA) United States $2.398B 0.00
Celldex Therapeutics (CLDX) United States $2.348B 0.00
Ginkgo Bioworks Holdings (DNA) United States $2.325B 0.00
Vera Therapeutics (VERA) United States $2.271B 0.00
Galapagos (GLPG) Belgium $2.239B 0.00
Guardant Health (GH) United States $2.159B 0.00
Vericel (VCEL) United States $2.137B 0.00
Janux Therapeutics (JANX) United States $2.038B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.998B 0.00
Sana Biotechnology (SANA) United States $1.958B 0.00
Avidity Biosciences (RNA) United States $1.947B 0.00
Twist Bioscience (TWST) United States $1.945B 0.00
Myriad Genetics (MYGN) United States $1.902B 0.00
NeoGenomics (NEO) United States $1.875B 0.00
Bavarian Nordic (BVNRY) Denmark $1.844B 6.05
Geron (GERN) United States $1.835B 0.00
Zai Lab (ZLAB) China $1.826B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.815B 15.09
Morphic Holding (MORF) United States $1.729B 0.00
Arcus Biosciences (RCUS) United States $1.725B 0.00
Kura Oncology (KURA) United States $1.701B 0.00
Protagonist Therapeutics (PTGX) United States $1.689B 0.00
Inhibrx (INBX) United States $1.659B 0.00
Structure Therapeutics (GPCR) United States $1.643B 0.00
Edgewise Therapeutics (EWTX) United States $1.575B 0.00
Dynavax Technologies (DVAX) United States $1.558B 0.00
Akero Therapeutics (AKRO) United States $1.550B 0.00
Disc Medicine (IRON) United States $1.491B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.471B 0.00
Vir Biotechnology (VIR) United States $1.453B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.412B 0.00
Prothena (PRTA) Ireland $1.400B 0.00
ANI Pharmaceuticals (ANIP) United States $1.391B 17.10
AbCellera Biologics (ABCL) Canada $1.379B 0.00
ADMA Biologics Inc (ADMA) United States $1.367B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.352B 0.00
CARGO Therapeutics (CRGX) United States $1.289B 0.00
89BIO (ETNB) United States $1.264B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.260B 0.00
Ligand Pharmaceuticals (LGND) United States $1.259B 15.59
Day One Biopharmaceuticals (DAWN) United States $1.257B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.251B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.248B 0.00
Immunome (IMNM) United States $1.231B 0.00
Kyverna Therapeutics (KYTX) United States $1.213B 0.00
Liquidia Technologies (LQDA) United States $1.209B 0.00
MannKind (MNKD) United States $1.209B 0.00
MiMedx (MDXG) United States $1.158B 262.67
Belite Bio (BLTE) United States $1.121B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.081B 0.00
Viridian Therapeutics (VRDN) United States $1.073B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.070B 0.00
Scholar Rock Holding (SRRK) United States $1.042B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.032B 0.00
Oric Pharmaceuticals (ORIC) United States $1.017B 0.00
Immatics (IMTX) Germany $1.017B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.016B 0.00
REGENXBIO (RGNX) United States $0.986B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.977B 0.00
Tango Therapeutics (TNGX) United States $0.921B 0.00
Pliant Therapeutics (PLRX) United States $0.915B 0.00
Cytek Biosciences (CTKB) United States $0.909B 0.00
Abivax SA (ABVX) France $0.878B 0.00
HilleVax (HLVX) United States $0.872B 0.00
Prime Medicine (PRME) United States $0.859B 0.00
Astria Therapeutics (ATXS) United States $0.849B 0.00
Cabaletta Bio (CABA) United States $0.803B 0.00
WAVE Life Sciences (WVE) Singapore $0.795B 0.00
Allogene Therapeutics (ALLO) United States $0.788B 0.00
Pharming Group (PHGUF) Netherlands $0.783B 0.00
Pharming Group (PHAR) Netherlands $0.771B 0.00
ACELYRIN, INC (SLRN) United States $0.763B 0.00
Zymeworks (ZYME) United States $0.763B 0.00
Tyra Biosciences (TYRA) United States $0.754B 0.00
Fate Therapeutics (FATE) United States $0.743B 0.00
Novavax (NVAX) United States $0.740B 0.00
Aerovate Therapeutics (AVTE) United States $0.739B 0.00
CureVac (CVAC) Germany $0.739B 0.00
EnGene Holdings (ENGN) United States $0.734B 0.00
Cogent Biosciences (COGT) United States $0.733B 0.00
Praxis Precision Medicines (PRAX) United States $0.730B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.714B 0.00
Fulcrum Therapeutics (FULC) United States $0.704B 0.00
PureTech Health (PRTC) United States $0.691B 0.00
Cullinan Oncology (CGEM) United States $0.686B 0.00
Editas Medicine (EDIT) United States $0.665B 0.00
Olema Pharmaceuticals (OLMA) United States $0.646B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.644B 0.00
Nurix Therapeutics (NRIX) United States $0.640B 0.00
Applied Therapeutics (APLT) United States $0.637B 0.00
Biomea Fusion (BMEA) United States $0.637B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.637B 0.00
Northwest Biotherapeutics (NWBO) United States $0.632B 0.00
AnaptysBio (ANAB) United States $0.628B 0.00
IGM Biosciences (IGMS) United States $0.625B 0.00
ArriVent BioPharma (AVBP) United States $0.623B 0.00
C4 Therapeutics (CCCC) United States $0.613B 0.00
Mersana Therapeutics (MRSN) United States $0.611B 0.00
Nkarta (NKTX) United States $0.597B 0.00
Alector (ALEC) United States $0.586B 0.00
Travere Therapeutics (TVTX) United States $0.570B 0.00
GH Research (GHRS) Ireland $0.567B 0.00
ALX Oncology Holdings (ALXO) United States $0.567B 0.00
Replimune (REPL) United States $0.524B 0.00
Mineralys Therapeutics (MLYS) United States $0.522B 0.00
Castle Biosciences (CSTL) United States $0.517B 0.00
Voyager Therapeutics (VYGR) United States $0.504B 3.00
PepGen (PEPG) United States $0.500B 0.00
Nuvation Bio (NUVB) United States $0.497B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.496B 0.00
Caribou Biosciences (CRBU) United States $0.485B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.483B 0.00
Arbutus Biopharma (ABUS) United States $0.470B 0.00
Adaptive Biotechnologies (ADPT) United States $0.470B 0.00
Revance Therapeutics (RVNC) United States $0.468B 0.00
Terns Pharmaceuticals (TERN) United States $0.465B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.461B 0.00
Ventyx Biosciences (VTYX) United States $0.456B 0.00
Absci (ABSI) United States $0.455B 0.00
MaxCyte (MXCT) United States $0.449B 0.00
Celcuity (CELC) United States $0.430B 0.00
Entrada Therapeutics (TRDA) United States $0.429B 0.00
Anavex Life Sciences (AVXL) United States $0.420B 0.00
Dianthus Therapeutics (DNTH) United States $0.416B 0.00
Oculis Holding AG (OCS) Switzerland $0.414B 0.00
Shattuck Labs (STTK) United States $0.414B 0.00
Alto Neuroscience (ANRO) United States $0.404B 0.00
MeiraGTx Holdings (MGTX) United States $0.404B 0.00
Avid Bioservices (CDMO) United States $0.398B 0.00
Invivyd (IVVD) United States $0.396B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.389B 0.00
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.379B 0.00
Jasper Therapeutics (JSPR) United States $0.378B 0.00
Third Harmonic Bio (THRD) United States $0.377B 0.00
Anika Therapeutics (ANIK) United States $0.372B 0.00
Inozyme Pharma (INZY) United States $0.364B 0.00
Annexon (ANNX) United States $0.356B 0.00
Precigen (PGEN) United States $0.356B 0.00
Amarin (AMRN) Ireland $0.353B 0.00
Adverum Biotechnologies (ADVM) United States $0.352B 0.00
AC Immune (ACIU) Switzerland $0.347B 0.00
TScan Therapeutics (TCRX) United States $0.341B 0.00
Urogen Pharma (URGN) United States $0.339B 0.00
Tenaya Therapeutics (TNYA) United States $0.339B 0.00
Atea Pharmaceuticals (AVIR) United States $0.338B 0.00
Humacyte (HUMA) United States $0.336B 0.00
Adlai Nortye (ANL) Cayman Islands $0.332B 0.00
Gossamer Bio (GOSS) United States $0.329B 0.00
FibroBiologics (FBLG) United States $0.328B 0.00
Erasca (ERAS) United States $0.323B 0.00
Kamada (KMDA) Israel $0.322B 24.35
Monte Rosa Therapeutics (GLUE) United States $0.321B 0.00
Nautilus Biotechnology (NAUT) United States $0.320B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.312B 0.00
Poseida Therapeutics (PSTX) United States $0.311B 0.00
Kodiak Sciences (KOD) United States $0.307B 0.00
XOMA (XOMA) United States $0.306B 0.00
Rapt Therapeutics (RAPT) United States $0.295B 0.00
Compass Therapeutics (CMPX) United States $0.292B 0.00
Stoke Therapeutics (STOK) United States $0.285B 0.00
Verastem (VSTM) United States $0.278B 0.00
Ocugen (OCGN) United States $0.277B 0.00
Aura Biosciences (AURA) United States $0.275B 0.00
Solid Biosciences (SLDB) United States $0.264B 0.00
Werewolf Therapeutics (HOWL) United States $0.262B 0.00
Inovio Pharmaceuticals (INO) United States $0.251B 0.00
Sutro Biopharma (STRO) United States $0.251B 0.00
UniQure (QURE) Netherlands $0.247B 0.00
Coherus BioSciences (CHRS) United States $0.247B 0.00
Mesoblast (MESO) Australia $0.247B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.242B 0.00
Akoya Biosciences (AKYA) United States $0.241B 0.00
Puma Biotechnology (PBYI) United States $0.241B 10.87
Compugen (CGEN) Israel $0.236B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.235B 0.00
Codexis (CDXS) United States $0.234B 0.00
Gritstone Bio (GRTS) United States $0.233B 0.00
Scilex Holding (SCLX) United States $0.228B 0.00
Agenus (AGEN) United States $0.226B 0.00
Greenwich LifeSciences (GLSI) United States $0.225B 0.00
Cardiff Oncology (CRDF) United States $0.225B 0.00
Lifecore Biomedical (LFCR) United States $0.224B 0.00
Repare Therapeutics (RPTX) Canada $0.223B 0.00
Alimera Sciences (ALIM) United States $0.220B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.219B 76.20
Inventiva S.A (IVA) France $0.219B 0.00
23andMe Holding (ME) United States $0.214B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.214B 0.00
Trevi Therapeutics (TRVI) United States $0.214B 0.00
Abeona Therapeutics (ABEO) United States $0.214B 0.00
Elevation Oncology (ELEV) United States $0.214B 0.00
Renovaro (RENB) United States $0.211B 0.00
ScPharmaceuticals (SCPH) United States $0.210B 0.00
Prima BioMed (IMMP) Australia $0.210B 0.00
CorMedix Inc (CRMD) United States $0.209B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.208B 0.00
2seventy Bio (TSVT) United States $0.206B 0.00
Innate Pharma S.A (IPHA) France $0.204B 0.00
Opthea (OPT) Australia $0.201B 0.00
Omega Therapeutics (OMGA) United States $0.200B 0.00
INmune Bio (INMB) United States $0.199B 0.00
Nuvectis Pharma (NVCT) United States $0.195B 0.00
Graphite Bio (GRPH) United States $0.195B 0.00
Ovid Therapeutics (OVID) United States $0.192B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.184B 0.00
Spyre Therapeutics (SYRE) United States $0.184B 0.00
ChromaDex (CDXC) United States $0.181B 0.00
XBiotech (XBIT) United States $0.180B 0.00
GENFIT S.A (GNFT) France $0.175B 0.00
Genelux (GNLX) United States $0.167B 0.00
Adocia (ADOCY) France $0.166B 0.00
Rani Therapeutics Holdings (RANI) United States $0.166B 0.00
G1 Therapeutics (GTHX) United States $0.162B 0.00
Bluebird Bio (BLUE) United States $0.155B 0.00
X4 Pharmaceuticals (XFOR) United States $0.155B 0.00
PDS Biotechnology (PDSB) United States $0.152B 0.00
DBV Technologies S.A (DBVT) France $0.152B 0.00
I-Mab (IMAB) China $0.150B 0.00
Design Therapeutics (DSGN) United States $0.144B 0.00
Molecular Partners AG (MOLN) Switzerland $0.144B 0.00
Cellectis S.A (CLLS) France $0.141B 0.00
Ocean Biomedical (OCEA) United States $0.140B 0.00
Adicet Bio (ACET) United States $0.140B 0.00
CytomX Therapeutics (CTMX) United States $0.140B 0.00
Sangamo Therapeutics (SGMO) United States $0.140B 0.00
Zura Bio (ZURA) United States $0.137B 0.00
ATyr Pharma (LIFE) United States $0.135B 0.00
NGM Biopharmaceuticals (NGM) United States $0.131B 0.00
Vor Biopharma (VOR) $0.131B 0.00
TELA Bio (TELA) United States $0.131B 0.00
Seer (SEER) United States $0.128B 0.00
Emergent Biosolutions (EBS) United States $0.128B 0.00
Clearside Biomedical (CLSD) United States $0.128B 0.00
Syros Pharmaceuticals (SYRS) United States $0.127B 0.00
Adagene (ADAG) China $0.126B 0.00
Genetron Holdings (GTH) China $0.123B 0.00
Kinnate Biopharma (KNTE) United States $0.121B 0.00
Vigil Neuroscience (VIGL) United States $0.120B 0.00
Vincerx Pharma (VINC) United States $0.119B 0.00
Seres Therapeutics (MCRB) United States $0.119B 0.00
Immunic (IMUX) United States $0.118B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.118B 0.00
BioAtla (BCAB) United States $0.117B 0.00
Alpha Teknova (TKNO) United States $0.116B 0.00
Allakos (ALLK) United States $0.115B 0.00
DiaMedica Therapeutics (DMAC) United States $0.115B 0.00
BeyondSpring (BYSI) United States $0.114B 0.00
Celularity (CELU) United States $0.110B 0.00
VistaGen Therapeutics (VTGN) United States $0.109B 0.00
IO Biotech (IOBT) Denmark $0.109B 0.00
Oncobiologics (OTLK) United States $0.107B 0.00
CervoMed (CRVO) United States $0.102B 0.00
Coya Therapeutics (COYA) United States $0.102B 0.00
BioHarvest Sciences (CNVCF) Canada $0.101B 0.00
Athira Pharma (ATHA) United States $0.100B 0.00
Eton Pharmaceuticals (ETON) United States $0.099B 0.00
Semper Paratus Acquisition (TVGN) United States $0.098B 0.00
Spero Therapeutics (SPRO) United States $0.096B 3.58
Annovis Bio (ANVS) United States $0.096B 0.00
Vaxxinity (VAXX) United States $0.096B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.095B 0.00
Cartesian Therapeutics (RNAC) United States $0.094B 0.00
Cue Biopharma (CUE) United States $0.093B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.093B 0.00
Lantern Pharma (LTRN) United States $0.093B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.091B 0.00
AN2 Therapeutics (ANTX) United States $0.089B 0.00
Equillium (EQ) United States $0.089B 0.00
Neurogene (NGNE) United States $0.088B 0.00
Sagimet Biosciences (SGMT) United States $0.086B 0.00
Passage Bio (PASG) United States $0.083B 0.00
BioXcel Therapeutics (BTAI) United States $0.081B 0.00
Instil Bio (TIL) United States $0.081B 0.00
Elutia (ELUT) United States $0.080B 0.00
Turnstone Biologics (TSBX) United States $0.077B 0.00
Ikena Oncology (IKNA) United States $0.076B 0.00
Oncolytics Biotech (ONCY) Canada $0.075B 0.00
Connect Biopharma Holdings (CNTB) United States $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Cognition Therapeutics (CGTX) United States $0.071B 0.00
InflaRx (IFRX) Germany $0.071B 0.00
Rezolute (RZLT) United States $0.071B 0.00
Eyenovia (EYEN) United States $0.070B 0.00
Aligos Therapeutics (ALGS) United States $0.069B 0.00
Affimed (AFMD) Germany $0.068B 0.00
Kronos Bio (KRON) United States $0.068B 0.00
YS Biopharma (YS) China $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.066B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.065B 0.00
Kezar Life Sciences (KZR) United States $0.064B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Atara Biotherapeutics (ATRA) United States $0.063B 0.00
Cidara Therapeutics (CDTX) United States $0.062B 0.00
Enzo Biochem (ENZ) United States $0.062B 0.00
Rallybio (RLYB) United States $0.061B 0.00
Curis (CRIS) United States $0.061B 0.00
HOOKIPA Pharma (HOOK) United States $0.060B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.060B 0.00
AVROBIO (AVRO) United States $0.058B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.057B 0.00
Leap Therapeutics (LPTX) United States $0.057B 0.00
Immuneering (IMRX) United States $0.056B 0.00
Beyond Air (XAIR) United States $0.056B 0.00
Bionano Genomics (BNGO) United States $0.055B 0.00
HCW Biologics (HCWB) United States $0.055B 0.00
Aadi Bioscience (AADI) United States $0.053B 0.00
Immix Biopharma (IMMX) United States $0.052B 0.00
Apollomics (APLM) Taiwan $0.052B 0.00
Clene (CLNN) United States $0.051B 0.00
Quince Therapeutics (QNCX) United States $0.050B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.049B 0.00
Lexaria Bioscience (LEXX) Canada $0.048B 0.00
Cara Therapeutics (CARA) United States $0.048B 0.00
BRIACELL THERAP (BCTX) Canada $0.047B 0.00
Ocuphire Pharma (OCUP) United States $0.047B 0.00
Carmell (CTCX) United States $0.047B 0.00
VTv Therapeutics (VTVT) United States $0.047B 0.00
Dare Bioscience (DARE) United States $0.046B 0.00
Precision BioSciences (DTIL) United States $0.046B 0.00
Checkpoint Therapeutics (CKPT) United States $0.045B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.045B 0.00
Candel Therapeutics (CADL) United States $0.043B 0.00
Dyadic (DYAI) United States $0.043B 0.00
NKGen Biotech (NKGN) United States $0.043B 0.00
Prenetics Global (PRE) Cayman Islands $0.043B 52.04
OKYO Pharma (OKYO) $0.043B 0.00
Gyre Therapeutics (GYRE) United States $0.042B 0.00
Bolt Biotherapeutics (BOLT) United States $0.042B 0.00
Elicio Therapeutics (ELTX) United States $0.042B 0.00
Pluri (PLUR) Israel $0.041B 0.00
Femasys (FEMY) United States $0.041B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
NextCure (NXTC) United States $0.040B 0.00
Entera Bio (ENTX) Israel $0.039B 0.00
LianBio (LIAN) United States $0.038B 0.00
Cyclo Therapeutics (CYTH) United States $0.038B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.037B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.037B 0.00
IN8bio (INAB) United States $0.036B 0.00
Promis Neurosciences (PMN) Canada $0.036B 0.00
Galena Biopharma (SLS) United States $0.035B 0.00
Evogene (EVGN) Israel $0.034B 0.00
Gamida Cell (GMDA) United States $0.034B 0.00
Spruce Biosciences (SPRB) United States $0.033B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Theratechnologies (THTX) Canada $0.030B 0.00
Biora Therapeutics (BIOR) United States $0.030B 0.00
SAB Biotherapeutics (SABS) United States $0.029B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.027B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.026B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Orgenesis (ORGS) United States $0.025B 0.00
ARCA Biopharma (ABIO) United States $0.025B 0.00
Aptose Biosciences (APTO) Canada $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Aprea Therapeutics (APRE) United States $0.023B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
CalciMedica (CALC) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Galecto (GLTO) Denmark $0.022B 0.00
Lumos Pharma (LUMO) United States $0.022B 0.00
Landos Biopharma (LABP) United States $0.021B 0.00
KALA BIO (KALA) United States $0.020B 0.00
Xilio Therapeutics (XLO) United States $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.019B 0.00
Purple Biotech (PPBT) Israel $0.018B 0.00
NuCana (NCNA) United Kingdom $0.018B 0.00
BioAffinity Technologies (BIAF) United States $0.018B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.017B 0.00
TFF Pharmaceuticals (TFFP) United States $0.017B 0.00
Fortress Biotech (FBIO) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.017B 0.00
Senti Biosciences (SNTI) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.017B 0.00
Moleculin Biotech (MBRX) United States $0.017B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Telesis Bio (TBIO) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Acorda Therapeutics (ACOR) United States $0.015B 0.00
RenovoRx (RNXT) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Seelos Therapeutics (SEEL) United States $0.014B 0.00
VBI Vaccines (VBIV) United States $0.013B 0.00
Benitec Biopharma (BNTC) United States $0.013B 0.00
Elevai Labs (ELAB) United States $0.013B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Evaxion Biotech (EVAX) Denmark $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
Galera Therapeutics (GRTX) United States $0.011B 0.00
Psyence Biomedical (PBM) United States $0.011B 0.00
Longeveron (LGVN) United States $0.011B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.011B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Trevena (TRVN) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.010B 0.00
Portage Biotech (PRTG) $0.010B 0.00
Monopar Therapeutics (MNPR) United States $0.010B 0.00
Cadrenal Therapeutics (CVKD) United States $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
AquaBounty Technologies (AQB) United States $0.008B 0.00
Imunon (IMNN) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Vaccinex (VCNX) United States $0.007B 0.00
Prana Biotechnology (ATHE) Australia $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Atreca (BCEL) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Soligenix (SNGX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Biorestorative Therapies (BRTX) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
NexImmune (NEXI) United States $0.006B 0.00
Virios Therapeutics (VIRI) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.006B 0.00
Enveric Biosciences (ENVB) United States $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Exicure (XCUR) United States $0.006B 0.39
Kineta (KA) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Atrinsic (PTIX) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Kintara Therapeutics (KTRA) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
NeuBase Therapeutics (NBSE) United States $0.004B 0.00
Notable Labs (NTBL) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
First Wave BioPharma (FWBI) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Sunshine Biopharma (SBFM) Canada $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Tenax Therapeutics (TENX) United States $0.001B 0.00
Cingulate (CING) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00